Decades of gains in the fight against AIDS are under growing threat as donor funding declines and community-based health services collapse in some of the world’s most vulnerable countries, the head of the joint UN programme on HIV/AIDS warned on Thursday. The sudden funding decline is hitting the HIV response “like a shock wave,” said…
Scientists in Mexican have used a specialised treatment to eliminate Human Papillomavirus (HPV), the virus responsible for most cases of cervical cancer, in a group of patients during clinical research. ALSO READ: Cervical cancer: Rwanda rolls out new HPV vaccine The research team led by Eva Ramón Gallegos, a scientist at Mexico’s National Polytechnic Institute,…
More than 25% of journalists do not receive a monthly salary, 42% earn below the national minimum wage, just 8% receive medical benefits and almost half of all journalists are not registered with the National Social Security Insurance Trust, denying them rights and benefits they are entitled to by law, according to the recently released…
Kinshasa / Paris / Geneva / Amsterdam — • Recommendation based on Phase II/III study demonstrating up to 96 per cent success rates at 18 months across both early and advanced stages of T.b. gambiense, the most common form of sleeping sickness • The therapy, given as a single dose of three tablets, could offer a simpler…
Nairobi — New HIV research presented this week at the Conference on Retroviruses and Opportunistic Infections (CROI 2026) has revealed critical evidence gaps that experts say must be urgently addressed to strengthen HIV treatment strategies across Africa. Researchers from the Centre for Epidemiological Modelling and Analysis (CEMA) at the University of Nairobi presented findings from…
Failure to adhere to HIV treatment is costing lives The Ndovu Study is strengthening HIV treatment by redefining how treatment failure and drug resistance are detected, managed, and prevented across Africa and beyond. Nairobi, KENYA (12 February 2026) — A new study is generating critical evidence to guide the optimal management of HIV patients who…
Scale-backs and deep spending cuts within the US government and the Global Fund to Fight AIDS are hobbling HIV treatment programs across Africa, including in Ethiopia, warns a new report from a UN health agency. “Before the funding cuts in 2025, Ethiopia was heavily dependent on external funding (mainly from the Global Fund and the…
IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing King Charles says his cancer treatment to be ‘reduced’ 00:29 UP NEXT Fed chair says buying a home unlikely to become easier soon 00:47 Fired Michigan football coach appears in court 01:10 Reddit sues Australian government over social…
Children and adolescents living with HIV-AIDS continue to be left behind in access to early diagnosis, life-saving treatment and care, as shrinking funding threatens to increase their risks and reverse decades of progress, Unicef warned ahead of World AIDS Day. A recently published Unicef-UNAIDS modelling shows that, if programme coverage falls by half, an additional…
Nairobi — A new study conducted across three African countries has found that an injectable HIV treatment–Cabotegravir/Rilpivirine (CAB LA + RPV LA), administered every two months–is safe, well tolerated, and preferred by most patients. The Month-12 results, drawn from study sites in Kenya, Uganda, and South Africa, offer renewed hope for improved treatment adherence, fewer…
